Global ELISA Tests Market, By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA), Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry and Transplantation, Infectious Diseases, Cancer, Protein Quantitation, Others), Technology (Chemiluminescent, Colorimetric, and Fluorescent), End User (Hospitals and Diagnostic Centers, Research Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The ELISA tests market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.23% in the forecast period of 2021 to 2028. The growing incidence of infectious diseases will help in escalating the growth of the ELISA tests market.
Enzyme-Linked Immunosorbent Assay (ELISA) is a test performed to detect the existence of antibodies in a biological liquid sample. ELISA is utilized as a quality control check in many industries and also as a diagnostic tool in plant pathology and in medicine.
Major factors that are expected to boost the growth of the ELISA tests market in the forecast period are the growing prevalence of infectious diseases such as the dengue, hepatitis, AIDS, and neurological disorders and cancer and the rising need for cost-effective diagnostic tools. Furthermore, the growing of elderly population and the arrival of cost efficient technologies and laboratory automation are few of the factors further anticipated to propel the growth of the ELISA tests market. However, the absence of accessibility and the cost efficient diagnostic tests further impedes the growth of the ELISA tests market in the timeline period. Additionally, the growth prospects in the advancing countries further provide potential opportunities for the growth of the ELISA tests market in the near future.
This ELISA tests market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ELISA tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
ELISA Tests Market Scope and Market Size
The ELISA tests market is segmented on the basis of method, application, technology and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the method, the ELISA tests market is segmented into direct ELISA, indirect ELISA, sandwich ELISA and competitive ELISA),
- Based on the application, the ELISA tests market is segmented into vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceutical industry and transplantation, infectious diseases, cancer, protein quantitation, others.
- Based on the technology, the ELISA tests market is segmented into chemiluminescent, colorimetric, and fluorescent.
- Based on the end user, the ELISA tests market is segmented into hospitals and diagnostic centers, research laboratories.
ELISA Tests Market Country Level Analysis
The ELISA tests market is analysed and market size insights and trends are provided by country, method, application, technology and end user as referenced above.
The countries covered in the ELISA tests market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the ELISA tests market because of the well-advanced healthcare infrastructure and the growing penetration of medical devices. Furthermore, high expenses on research and development by the government organizations and the pharmaceutical companies for disorders and diseases like chronic ailments and diabetes will further boost the growth of the ELISA tests market in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the ELISA tests market because of the increase in the disposable income and healthcare expenditure in the developing countries. Furthermore, the rise in the adoption of medical devices in advanced countries is further anticipated to propel the growth of the ELISA tests market in the coming years.
The country section of the ELISA tests market report also provides individual market-impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The ELISA tests market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for ELISA tests market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the ELISA tests market. The data is available for historic period 2010-2019.
Competitive Landscape and ELISA Tests Market Share Analysis
The ELISA tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to ELISA tests market.
The major players covered in the ELISA tests market report are Ortho-Clinical Diagnostics, Thermo Fisher Scientific, ZEUS Scientific, Inc., ALPCO, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Enzo Life Sciences, Inc., Merck KGaA, BioLegend, Inc., LOEWE Biochemica GmbH, Creative Diagnostics., Arigo biolaboratories Corp., ELISA Technologies, Inc., RayBiotech, Inc., R&D Systems, Inc., AESKU.GROUP GmbH & Co. KG, Cell Technology., Arbor Assays, Eurofins Scientific, Biogenuix, F. Hoffmann-La Roche Ltd, Abbott, Danaher., Sysmex Corporation, PerkinElmer Inc., Agilent Technologies., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.